The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Herbalife Ltd

NYSE: HLF
Last

(U.S.) $43.25

Today's change-0.14 -0.32%
Updated November 28 1:01 PM EST. Delayed by at least 15 minutes.
 

Herbalife Ltd

NYSE: HLF
Last

(U.S.) $43.25

Today's change-0.14 -0.32%
Updated November 28 1:01 PM EST. Delayed by at least 15 minutes.

Herbalife Ltd down (U.S.)$0.14

Herbalife Ltd closed lower Friday, dropping (U.S.)$0.14 or 0.32% to (U.S.)$43.25. Over the last five days, shares have gained 5.88%, but are down 45.04% for the last year to date. Shares have underperformed the S&P 500 by 52.34% during the last year.

Key company metrics

  • Open(U.S.) $43.42
  • Previous close(U.S.) $43.39
  • High(U.S.) $43.67
  • Low(U.S.) $43.00
  • Bid / Ask(U.S.) $43.00 / (U.S.) $43.50
  • YTD % change-45.04%
  • Volume1,804,798
  • Average volume (10-day)2,399,464
  • Average volume (1-month)3,592,826
  • Average volume (3-month)2,487,575
  • 52-week range(U.S.) $36.97 to (U.S.) $83.51
  • Beta1.46
  • Trailing P/E12.94×
  • P/E 1 year forward7.34×
  • Forward PEG3.06×
  • Indicated annual dividend--
  • Dividend yield2.77%
  • Trailing EPS(U.S.) $3.34
Updated November 28 1:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.46%

Based on its net profit margin of 6.46%, Herbalife Ltd is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,2561,3061,2631,269
Total other revenue--------
Total revenue1,2561,3061,2631,269
Gross profit1,0011,0491,0111,017
Total cost of revenue255257251252
Total operating expense1,2291,1101,1351,087
Selling / general / administrative956858879836
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income28196128182
Interest income (expense), net non-operating-24-24-18-5
Gain (loss) on sale of assets--------
Other--------
Income before tax-2175109179
Income after tax1112075124
Income tax, total-13553555
Net income1112075124
Total adjustments to net income--------
Net income before extra. items1112075124
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1112075124
Inc. avail. to common incl. extra. items1112075124
Diluted net income1112075124
Dilution adjustment--00--
Diluted weighted average shares8691101107
Diluted EPS excluding extraordinary itemsvalue per share0.131.310.741.16
Dividends per sharevalue per share0.000.000.300.30
Diluted normalized EPSvalue per share0.131.310.741.16